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Background: The evidence regarding thoracic aortic calcification (TAC) as a potential independent risk factor for cardiovascular disease (CVD) and 
mortality is mixed. However, many studies consider TAC as a single anatomic entity, when in fact the ascending and descending aorta are subject to 
different physiologic stresses. We hypothesized that ascending thoracic aortic calcification (ATAC) and descending thoracic aortic calcification (DTAC) 
may predict distinct clinical profiles of CVD. To test this hypothesis, we examined whether ATAC and DTAC have differential associations with CVD risk 
factors in diabetics.
Methods: Within the Penn Diabetes Heart Study, a cross-sectional study of individuals with type 2 diabetes without coronary or renal disease, we 
measured ATAC and DTAC Agatston calcium scores in all subjects with a baseline electron beam cardiac CT (N=1743, 63% male, 61% Caucasian). 
Multivariable logistic and tobit regression with stepwise backward elimination was used for analysis.
Results: The prevalence of ATAC and DTAC was 43.3% and 34.3% respectively, with 19.8% having only ATAC, 10.7% only DTAC, and 23.7% 
both. In multivariate analysis, the presence and extent of ATAC and DTAC were associated with age, Caucasian race, and hypertension. ATAC was 
also associated with dyslipidemia [OR 2.24 (95% CI 1.66-3.02), p<0.001] and tobacco use [OR 1.29 (1.03-1.61), p=0.03], whereas DTAC was 
associated with an ankle-brachial index of ≤0.9 [OR 1.62 (1.10-2.41), p=0.02]. Both ATAC and DTAC Agatston scores were associated independently 
of each other with increasing CAC scores in fully adjusted tobit regression models (p <0.04 for all groups of ATAC and DTAC scores 1-100, 100-500 
and >500 vs. 0). Neither ATAC nor DTAC was associated with renal function, severity or duration of diabetes, BMI or CRP.
Conclusions: Within this diabetic population, ATAC appears to be associated more with cardinal CVD risk factors, whereas DTAC has a strong 
relationship with peripheral arterial disease. However, both are independently associated with CAC. Identification of these phenotypes should aid in 
determining whether these disease markers translate into meaningful differences in CVD risk prediction and mortality.
